The high-mobility group I (HMGI) proteins (HMGI, HMGY, and HMGI-C) are small, highly charged polypeptides of about 100 amino acids which constitute an important component of active chromatin structure. Evidence is accumulating of their biological functions (9, 13, 33, 38, 41, 46) : in vitro they bind to AT-rich DNA sequences, specifically within the minor groove (12, 34, 35, (38) (39) (40) (41) and in particular at scaffold-associated regions, and they are associated with many highly transcribed and regulated genes derepressing their transcription in vitro (46) . It has also been demonstrated that the HMGI(Y) proteins are implicated in regulating the expression of tumor necrosis factor beta in murine leukemia virus-transformed cells (13) and can cooperate with the NF-B factor, ATF-2 homodimer, and ATF-2/c-Jun heterodimer in the viral induction of the human beta interferon gene (9, 41) .
The HMGI and HMGY proteins have been well characterized, and cloning of their cDNAs has shown that they are products of the same gene via an alternative splicing mechanism (10, 15, 26, 27) . It is therefore common to designate both proteins and the corresponding gene with the abbreviation HMGI(Y). The molecular cloning of the cDNA for mouse HMGI-C has demonstrated that the HMGI-C protein, although related to HMGI(Y), is the product of a different gene (31) .
A correlation between elevated expression of the three HMGI proteins and the appearance of a highly malignant phenotype in differentiated rat thyroid cells transformed with several oncogenes has been demonstrated (21, 23) . Experimental mouse carcinomas induced by dimethylbenzanthracene and rat thyroid carcinomas induced by Kirsten murine sarcoma virus (KiMSV) exhibited high levels of expression of these three proteins (22) . Conversely, all mammalian normal adult tissues so far investigated express undetectable or very low levels of HMGI proteins (19-21, 26, 31) . More recently, an association has been demonstrated between elevated expression of the HMGI(Y) gene and progressive transformation of mouse mammary epithelial cells (33) , and a correlation has been shown between HMGI(Y) gene overexpression and the ability of rat prostatic carcinoma cell lines to metastasize. Such observations suggest that these proteins might be considered potential tumor progression markers (7) . Furthermore, the human homolog of the Drosophila trithorax protein (HRX), structurally altered by the 11q23 chromosomal translocations in human acute leukemia, carries an amino-terminal motif related to the DNA-binding motifs of HMGI proteins (42) 
The correlation between the level of HMGI proteins and the malignant phenotype makes it important to determine their role in the process of cell transformation and in particular to investigate whether their increase is a phenomenon peripherally associated with cell transformation or is in causal relation to the expression of the malignant phenotype.
To approach this question, we have transfected two differentiated rat thyroid cell lines (PC Cl 3 and FRTL-5 Cl 2) with an antisense construct for the HMGI-C cDNA. These cells were then infected with myeloproliferative sarcoma virus (MPSV) or KiMSV, both of which are able to drive these normal cells to the malignant phenotype (17, 18) . In contrast to untransfected cells or those transfected with the sense construct, virally infected cells containing the antisense construct did not demonstrate the malignant phenotype, even though the parameters of thyroid differentiation were lost and the viral oncogenes were abundantly expressed.
MATERIALS AND METHODS
Cells and viruses. PC Cl 3 rat thryoid cells are derived from 18-month-old Fischer rats (16) , and FRTL-5 cells are derived from 3-to 4-week-old normal Fischer rats (1) . The normal and virally infected cells were grown in Coon's modified Ham's F12 medium supplemented with 5% calf serum (Gibco Laboratories) and with a hormone mixture containing 10 Ϫ10 M thyroid-stimulating hormone (TSH), 10 g of insulin per ml, 10 Ϫ8 M hydrocortisone, 5 g of human transferrin per ml, 10 ng of somatostatin per ml, and 10 ng of glycyl-L-histidyl-L-lysine acetate per ml. Infection with KiMSV and MPSV was carried out as described previously (16) (17) (18) . All transfections were performed by the calcium phosphate procedure as described elsewhere (24) .
Assay of the transformed state. Tumorigenicity of the cell lines was tested by injecting 2 ϫ 10 6 cells subcutaneously into athymic mice. Soft agar colony assays were performed as described previously (29) .
RNA isolation and Northern (RNA) analysis. Total RNA was extracted by a modification of the guanidine thiocyanate method (36) . Northern blots and hybridizations were carried out as previously described (37) . The probes used were (i) a 680-bp EcoRI-PstI fragment corresponding to the 3Ј end of the rat thyroglobulin (TG) gene (8), (ii) the purified insert from clone T8AFB which represents residues Ϫ54 to 2780 of the rat TSH receptor gene, a generous gift of L. D. Kohn (3); (iii) a 0.7-kb EcoRI-SacI fragment corresponding to the 5Ј coding region of the rat thyroperoxidase (TPO) gene; (iv) the insert of the HiHi3 clone as a v-ras-Ki-specific probe (11); and (v) v-mos oncogene sequences as previously described (44), a generous gift of S. A. Tronick. Finally, HMGI probes were pHMGI(Y) for the HMGI(Y) gene (26) and pHMGI-C11a1 for the murine HMGI-C gene (32) .
RT-PCR. RNA amplification was done by the method of Kawasaki (28) . Sequences of the sense and antisense HMGI-C primers were as follows: HMGI-C(s), 5Ј-GCAGCAAAAACAAGAGCC-3Ј (sense); and HMGI-C(as), 5Ј-GC GAGGATGTCTCTTCAG-3Ј (antisense). These primers were designed on the basis of the cDNA sequence of the HMGI-C gene (nucleotides 247 to 264 and 373 to 390, respectively) (31) . The expected size of the amplified product was 143 bp. To remove trace amounts of contaminating genomic DNA, RNAs were pretreated with RNase-free DNase (Boehringer Mannheim) for 30 min at 37ЊC as instructed by the manufacturer. Strand-specific reverse transcriptase PCR (RT-PCR) was performed in order to differentiate the expression of the sense and antisense HMGI-C constructs. Briefly, 5 g of total RNA was reverse transcribed by using the sense primer (for expression of the antisense construct) or the antisense primer (for expression of the sense construct), and PCR was performed by subsequently adding the antisense or sense primer, respectively. Thirty cycles of PCR were performed with a thermal cycler (Perkin-Elmer Cetus) (94ЊC for 30 s, 55ЊC for 1 min, and 72ЊC for 2 min). As a control for the quality of the RNA preparations used, expression of the rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene was monitored. Oligonucleotide primer sequences used to amplify GAPDH mRNA were GAPDH-F (5Ј-TTCACCAC CATGGAGAAGGCT-3Ј [forward]) and GAPDH-R (5Ј-ACAGCCTTGGCA GCACCAGT-3Ј [reverse]), designed on the basis of the cDNA sequence (nucleotides 369 to 389 and 696 to 715, respectively) (14) . To ensure no contamination of RNA samples with DNA, negative controls were obtained by performing the PCRs also on samples that were not reverse transcribed but otherwise identically processed.
Run-on assays. Preparation of nuclei, RNA elongation, and RNA isolation were performed as described previously (25) except that nuclei were frozen at Ϫ80ЊC before use and the labelled RNA was treated with RNase-free DNase (Boehringer Mannheim) for 30 min at 37ЊC. A total of 2 ϫ 10 7 nuclei were used for each assay. About 4 ϫ 10 6 cpm was hybridized to an excess of target DNA (10 g) immobilized on a nitrocellulose filter. The hybridization conditions were 50% formamide, 5ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate), 5ϫ Denhardt's solution, 50 mM phosphate buffer (pH 7.0), 0.1% sodium dodecyl sulfate (SDS), and 10 g of pGEM vector DNA per ml at 37ЊC for 3 days. The following plasmids were used as DNA targets: mouse ␤-actin (43), pTG (8), pHMGI-C11A1 (31) , and pHMGI(Y) (26) .
Protein extraction and Western blot (immunoblot) analysis. HMG proteins were selectively extracted with 5% (vol/vol) perchloric acid and precipitated with acetone-HCl, and acetic acid-urea electrophoretic analyses were carried out as elsewhere described (21, 23) . Acetic acid-urea gels for Western analysis were obtained by loading each lane with the same amount of total protein (40 g). Parallel gels were run to ascertain that equal amounts of protein had in fact been loaded by staining with Coomassie blue and checking the level of histone H1, whose expression can be assumed to be constant in the different cell lines (20) . For blotting experiments, acetic acid-urea gels were incubated in 0.75 M Tris base-0.1% SDS for 15 min and then transferred to an Immobilon-P membrane with a semidry apparatus, by using 75 mM Tris base-0.01% SDS for 30 min at 10 V. Transfers were first saturated with 0.05 M Tris (pH 7.5)-0.5 M NaCl-5% (mass/vol) nonfat dried milk-0.05% Tween 20-0.2% bovine serum albumin and then incubated with anti-HMGI-C affinity-purified antibody (diluted 1:30) for 1 h at room temperature. After incubation, the membranes were washed three times with the saturation solution and then incubated with goat anti-rabbit immunoglobulin G (heavy plus light chain) horseradish peroxidase-conjugated antibody (1:1,000; Pierce) for 1 h at room temperature. Transfers were then washed with the same buffer, rinsed with 0.02 M Tris (pH 7.5)-0.5 M NaCl, and developed with 0.3% (mass/vol) 4-chloro-naphthol (Sigma) in cold methanol mixed 1:5 with 0.02 M Tris (pH 7.5)-0.5 M NaCl. Finally, H 2 O 2 (30% solution) was added (1:2,000), and the reaction was stopped by washing with phosphatebuffered saline.
RESULTS
HMGI gene expression and regulation in transformed thyroid cells. To evaluate the role of the HMGI proteins in cell transformation, we used the thyroid cell system originally developed in our laboratories. Two rat thyroid epithelial cell lines (FRTL-5 Cl 2 and PC Cl 3) expressing thyroid differentiation markers (TG synthesis and secretion, uptake of iodide, and dependence on TSH for growth) have been infected with a wide variety of murine retroviruses carrying different oncogenes. The infection results in loss of the differentiation markers, but the fully transformed phenotype is not always obtained. There are, in fact, cell lines that do not show any of the neoplastic phenotypic markers, other cell lines that show a weak tumorigenic phenotype with the appearance of noninvasive tumors only after 4 to 5 weeks, and finally cell lines which show a highly malignant phenotype since they induce within 7 to 10 days large invasive tumors that lead eventually to animal death (3, 5, 6, (16) (17) (18) . Table 1 summarizes the cell phenotypes  studied. A correlation has been demonstrated between the presence of the HMGI proteins and the expression of a highly malignant phenotype (21, 23) . To investigate the possible molecular mechanism of this association, we analyzed normal and transformed cell lines for the expression of the HMGI(Y) and HMGI-C genes by Northern blot analysis. The data obtained (summarized in Table 1) show that only the highly neoplastic cells express the HMGI genes, and these results therefore confirm those obtained at the protein level for the same cell lines (23) . Representative data shown in Fig. 1A demonstrate that HMGI expression is present only in the PC E1Aϩv-raf, PC E1Aϩv-abl, PC MPSV, and FRTL-5 KiMSV cell lines, which are characterized by a highly malignant phenotype, whereas no expression is detectable in normal cells and in PC v-raf cells, which also do not show the fully malignant phenotype. Run-on assays were performed to ascertain whether this induction was at the transcriptional level. Figure 1B clearly shows that the transcriptional activity of the HMGI-C and HMGI(Y) genes is high in PC MPSV cells; conversely, in normal PC Cl 3 cells, there is no difference from background levels. Among the control genes, we used the TG gene, which undergoes a transcriptional block in transformed thyroid cells (4) . Almost identical results were obtained for normal and KiMSV-transformed FRTL-5 Cl 2 cells (data not shown). The induction of HMGI(Y) and HMGI-C gene expression therefore occurs at the transcriptional level in transformed cells. Since the rate of HMGI synthesis is known to vary during the cell cycle (32) , all cell lines were harvested for RNA extraction and run-on experiments when the cells were at a confluent stage. The results of these experiments were confirmed when the quiescent state of growth was obtained by starving the cells for 3 days in the absence of serum and six exogenously added growth factors (data not shown). In addition, differences in HMGI expression between normal and transformed thyroid cell lines cannot be ascribed to the different rates of cellular proliferation since in most of the cells analyzed (for instance, normal FRTL-5 Cl 2 and transformed FRTL-5 KiMSV), the rate of proliferation is almost the same between normal and transformed cells (6, 16, 17) . However, to exclude the possibility that these expression levels reflect changes in the fraction of cells that are replicating rather than the transformed state, we analyzed HMGI expression in normal and transformed PC Cl 3 and FRTL-5 Cl 2 cells in the logarithmic phase of growth. As shown in Fig. 2 , also in the logarithmic growth phase, the normal thyroid cells (PC Cl 3 and FRTL-5 Cl 2) and the nontumorigenic infected cell lines (PC v-raf and PC E1A) were negative for HMGI gene expression; in contrast, transformed PC MPSV, PC E1Aϩmiddle T, PC E1Aϩv-raf, and FRTL-5 KiMSV cells were also consistently positive in the proliferating phase. Both the quiescent (cells starved for 3 days) and the logarithmic phases were confirmed with a thymidine incorporation assay (not shown).
Transfection of thyroid cells with an antisense HMGI-C construct prevents the appearance of the malignant phenotype. To understand whether the overexpression of HMGI genes is important in the process of cell transformation or arises as a result of it, we introduced an antisense construct of the HMGI-C cDNA into normal PC Cl 3 and FRTL-5 Cl 2 cells, pursuing the aim of blocking the synthesis of this protein. Figure 3 shows the maps of the constructs used. The pMV-7-HMGI-C sense and antisense constructs were obtained by inserting the HMGI-C cDNA (31) in both sense and antisense orientations in the retroviral vector pMV-7 under the transcriptional control of the long terminal repeats of Moloney murine leukemia virus (30) . This vector also carries the gene for geneticin resistance.
Both the sense and antisense constructs were then used to transfect normal PC Cl 3 and FRTL-5 Cl 2 cells. Geneticinresistant clones were isolated, and expression of the sense (not shown) and antisense HMGI-C constructs (Fig. 4) was analyzed by strand-specific RT-PCR. Three transfectants per line were selected on the basis of their capability to express the (Table 2 and data not shown).
The PC pMV-7-HMGI-C sense and antisense and the FRTL-5 pMV-7-HMGI-C sense and antisense transfectants (three per line) were then infected with MPSV and KiMSV carrying, respectively, the v-mos and v-ras-Ki oncogenes. These viruses were chosen since it has been demonstrated ( Table 1) that they are able to induce the fully neoplastic phenotype in PC Cl 3 and FRTL-5 Cl 2 cells, respectively. After infection, the majority of cells showed morphological changes, and they were then selected for the capability to grow in the absence of TSH. For both cell types, the TSH-independent clones carrying the pMV-7-HMGI-C antisense construct showed an increased adhesion to the plate in comparison with the analogous infected cells carrying the pMV-7-HMGI-C sense construct (data not shown). Moreover, the virally infected cells carrying the pMV-7-HMGI-C antisense construct still showed an epithelial morphology, a feature completely lost in the normal or pMV-7-HMGI-C sense-transfected cells when infected with the same viruses (Fig. 5) . Three independent clones and one mass population of infected cells were isolated after infection of each antisense-transfected cell clone.
The growth rate and TSH dependency were analyzed. The growth curves of PC Cl 3 and FRTL-5 Cl 2 cells expressing the sense or antisense HMGI-C construct perfectly overlapped those of untransfected cells (data not shown). Figure 6 shows that the PC pMV-7-HMGI-C antisense, MPSV-infected cells, in contrast with the normal PC Cl 3 cells, were able to grow also in the absence of the six growth factors but with a reduced growth rate in comparison with the untransfected or sensetransfected PC Cl 3 cells infected with MPSV. Likewise, the FRTL-5 pMV-7-HMGI-C antisense cells infected with KiMSV also showed a loss of dependency on the six growth factors and a reduced growth rate in comparison with the same infected cells with or without the sense construct (data not shown). No differences have been observed among the different homogeneous clones; therefore, these results pertain to one representative clone.
The neoplastic phenotype was evaluated in different cell clones, derived from the infection of different PC Cl 3 and FRTL-5 HMGI-C antisense-transfected clones, by the colonyforming assay in soft agar and by injecting 2 ϫ 10 6 cells into athymic mice. No tumors were induced after injection of the virally infected cells carrying the pMV-7-HMGI-C antisense construct even after 4 months, nor were the same cells able to grow in soft agar. In contrast, the untransfected cells or those transfected with the sense construct, when infected, showed a high colony-forming efficiency in agar and induced subcutaneous tumors that appeared with a short latency period (1 to 2 weeks) ( Table 2) .
Expression of viral oncogenes and of thyroid differentiated functions in HMGI-C sense-and antisense-transfected thyroid cells. To exclude the possibility that the prevention of thyroid cell transformation caused by the pMV-7-HMGI-C antisense construct was due to the lack of expression of viral oncogenes in the cells carrying that construct, we evaluated mRNA levels of the v-mos and v-ras-Ki oncogenes in the MPSV-and KiMSV-infected cells carrying both the HMGI-C sense and antisense constructs. Northern blot analysis revealed no differences in the expression levels of v-ras-Ki (Fig. 7A ) and v-mos (Fig. 7B) oncogenes between HMGI-C sense-and antisensetransfected PC Cl 3 and FRTL-5 Cl 2 cells infected with the respective retroviruses. Expression of the typical thyroid functions, TG, TPO, and the TSH receptor, was also analyzed in the same cells by Northern blotting (Fig. 8) . The TG gene was not expressed in any of the infected cells lines; the TSH re- (Fig. 8) .
As already reported (17, 18) , no expression of the differentiated thyroid markers was detected in PC Cl 3 or FRTL-5 Cl 2 cells infected with MPSV or KiMSV. Analysis of the HMGI proteins in normal, transformed, and HMGI-C sense-and antisense-transfected thyroid cells. Western blot analyses of total proteins extracted from normal, transformed, and antisense-transfected cells were carried out ( Fig. 9 ) with polyclonal antibodies raised against the recombinant HMGI-C protein (32) . Since HMGI-C shows about 50% sequence identity with the other two HMGI proteins (HMGI and HMGY), the antibodies also recognized the HMGI and HMGY proteins. The antibody was tested both on total HMG extracts from mouse Lewis lung carcinoma (lane 3), which has been demonstrated to express the three HMGI proteins, and on high-pressure liquid chromatography (HPLC)-purified HMGI-C, HMGI, and HMGY proteins (lane 4).
Lanes 1 and 2 show Coomassie blue-stained proteins which were used in lanes 3 and 4 to test the antibodies. Lanes 5 to 9 show Western blot analysis of protein extracted from virally infected cells, transfected or not with the HMGI-C antisense construct. To estimate the amounts of total protein loaded, a parallel gel was run for each sample and stained with Coomassie blue (lanes 5Ј to 9Ј). Histone H1, whose expression can be assumed to be constant in the different cell lines, was used as a reference (20) .
First-dimension acetic acid-urea electrophoresis, such as in lanes 5 to 9, does not allow the resolution of the variety of components which are present in a perchloric acid extract of cells. This resolution can be achieved by second-dimension SDS electrophoretic analysis (21) (22) (23) . However, first-dimension acetic acid-urea electrophoresis allows very good resolution of the three proteins HMGI, HMGY, and HMGI-C, which can be easily identified by Western blot analysis. In the first dimension, protein HMGY migrates close to protein HMG14 (which together with protein HMG17 is present in all normal mammalian cells) and to an unknown component that is probably a degradation product, as previously reported (19) .
The untransfected, virally infected cells (lanes 6 and 8) showed high levels of the three HMGI proteins in comparison with normal cells (lane 5). In contrast both PC pMV-7-HMGI-C antisense MPSV-infected and FRTL-5 pMV-7-HMGI-C antisense KiMSV-infected cells (lanes 7 and 9) revealed a great reduction in the expression of HMGI-C protein and the complete absence of HMGI and HMGY proteins. The absence of HMGI and HMGY is also evident from the Coomassie blue-stained lanes 7Ј and 9Ј.
The amount of HMGI/Y/I-C mRNA in the HMGI-C antisense-transfected, virally infected cells was also evaluated (Fig.  10) . The levels of HMGI-C mRNAs (evaluated by hybridization with a riboprobe prepared from the HMGI-C cDNA) were much lower in the transfected cells than in the untransfected, virally infected cells. In accordance with Western data, no expression of the HMGI(Y) gene was observed in the antisense-transfected, virally infected cells. These results were obtained for different clones of virally infected, HMGI-C antisense-transfected thyroid cells. Two hypotheses can be envisaged to account for the absence of HMGI(Y) in these cells. Blockage of HMGI-C protein synthesis, thereby preventing rat thyroid cell transformation, may also suppress the appearance of the HMGI(Y) as a secondary consequence. Alternatively, the HMGI-C antisense construct may also be able per se to block the synthesis of the HMGI(Y) proteins, since there is a fair level of identity between the HMGI-C gene and the HMGI(Y) gene. However, the complete absence of HMGI(Y)-specific mRNA in the antisense-transfected, virally infected cells makes the second hypothesis less likely. 
DISCUSSION
Our data demonstrate that a high level of expression of at least one of the HMGI proteins, HMGI-C, is an important event in the process of cell transformation. We have obtained an antisense construct able to block the expression of the HMGI-C gene; the introduction of this antisense construct into two rat thyroid cell lines before infection with retroviruses carrying a transforming oncogene prevented their progression toward the neoplastic phenotype without interfering with retroviral infection. The molecular mechanisms underlying this action are still to be defined. It has been demonstrated that the HMGI proteins bind to AT-rich regions and regulate the expression of the lymphotoxin and rRNA genes (13, 45) . Moreover, HMGI(Y) proteins cooperate with both nuclear factors NF-B and ATF-2/c-Jun heterodimer in the activation of the human beta interferon gene (9, 41) . This cooperation is caused by protein-protein interactions between HMGI(Y) and the p50 subunit of NF-B or both ATF-2 and c-Jun subunits. On the other hand, c-Jun participates with c-Fos in formation of the AP-1 complex (2), and therefore it can be postulated that HMGI proteins are involved, through an interaction with c-Jun of the AP-1 heterodimer, in the regulation of expression of several genes that are important for the induction of the malignant phenotype. Future studies will be carried out to identify genes that are activated by the HMGI-C protein, alone or associated with other factors. Interestingly, the c-myc oncogene is highly expressed in PC MPSV cells and is expressed at low levels in normal and slightly tumorigenic cells. The c-myc oncogene is thus a candidate gene for regulation by the HMGI-C protein. Preliminary data indicate that c-myc expression decreases in all infected thyroid cells carrying the HMGI-C antisense construct.
Since no presence of HMGI proteins is detected in normal thyroid cells, we have to assume that the v-mos and v-ras-Ki oncogenes are able to induce the synthesis of the HMGI proteins, and since the block of this induction by the presence of an antisense construct inhibits cell transformation, we conclude that HMGI expression has a causal relationship with the establishment of the neoplastic phenotype induced by these oncogenes. In addition, we have preliminary results indicating that transfection of the same antisense construct into already transformed PC MPSV or FRTL5 KiMSV cells is able to induce a clear morphological change resembling a reversion to the normal phenotype, with the transfected cells appearing less refractile and more adherent to the surface than the untransfected cells. However, this reversion was only transitory, since after a few (three to five) passages in culture, the cells again acquired the transformed morphology. Experiments are in The HMGI-C gene does not behave like a classical transforming oncogene, since when transfected in normal thyroid cells, it did not cause their transformation, thus suggesting that its expression is necessary but not sufficient to achieve the transformed phenotype; the activation of other factors could be required. The important role of HMGI proteins in cell transformation does not seem to be restricted to thyroid cells, since recent data obtained in our laboratories indicate that the HMGI-C antisense constructs are also able to prevent neoplastic transformation of murine keratinocytes. The role of the HMGI proteins in human thyroid carcinomas also needs to be elucidated; preliminary data indicate that the HMGI proteins are present in human thyroid carcinoma cell lines (7a) but not in normal thyroid or nonneoplastic thyroid proliferative disorders. An important role for HMGI proteins in human thyroid carcinomas must therefore be considered.
